MIM
NUVB.WS

Monashee Investment Management’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

Monashee Investment Management’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-26,666
Closed -$68K – 95
2021
Q3 		$68K Hold
26,666
– – 0.01% 193
2021
Q2 		$69K Hold
26,666
– – 0.01% 350
2021
Q1 		$71K Buy
+26,666
New +$77.1K 0.01% 317

Other funds holding NUVB.WS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Monashee Investment Management's NUVB.WS Position: Q4 2021 in Review

Monashee Investment Management sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q4 2021, closing a stake of 26,666 shares — an estimated $68K sold.

Monashee Investment Management first reported a position in NUVB.WS in Q1 2021 and held it in 3 quarters. The position peaked at $71K in Q1 2021. 19 funds tracked by Wall St. Rank hold NUVB.WS as of Q4 2021.

  • Monashee Investment Management reported no remaining Nuvation Bio Inc Warrants position as of Q4 2021 after selling out during the quarter.
  • Monashee Investment Management sold 26,666 Nuvation Bio Inc Warrants shares in Q4 2021, an estimated $68K.
  • Monashee Investment Management first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 3 quarters.
  • Monashee Investment Management's Nuvation Bio Inc Warrants position peaked at $71K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q4 2021.

Based on Monashee Investment Management's 13F filing for Q4 2021, filed 7 Feb 2022.